Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chevalier

Showing results (161-170 of 183) with videos related to

Pageof 19
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 3, 2014
Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological SocietyG Succo, G Peretti, C Piazza, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|August 18, 2020
Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL), part II: Management of recurrent pleomorphic adenoma of the parotid glandO Malard, J Thariat, C Cartier, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|October 16, 2020
Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL), part I: Primary treatment of pleomorphic adenomaS Vergez, N Fakhry, C Cartier, et al.
International Journal for Parasitology|April 14, 2016
Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome populationFrédéric D Chevalier, Winka Le Clec'h, Nina Eng, et al.
Pharmaceutics|July 27, 2022
Schistosome Sulfotransferases: Mode of Action, Expression and LocalizationMeghan A Guzman, Anastasia Rugel, Sevan N Alwan, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 22, 2020
Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?Anastasia R Rugel, Meghan A Guzman, Alexander B Taylor, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
ACS Medicinal Chemistry Letters|October 23, 2018
Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal AgentsAnastasia Rugel, Reid S Tarpley, Ambrosio Lopez, et al.
Plos Neglected Tropical Diseases|August 19, 2020
An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humansMeghan A Guzman, Anastasia R Rugel, Reid S Tarpley, et al.
Molecular Biology and Evolution|June 29, 2019
Ancient Hybridization and Adaptive Introgression of an Invadolysin Gene in Schistosome ParasitesRoy N Platt, Marina McDew-White, Winka Le Clec'h, et al.
Pageof 19

Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 3, 2014
Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological SocietyG Succo, G Peretti, C Piazza, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|August 18, 2020
Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL), part II: Management of recurrent pleomorphic adenoma of the parotid glandO Malard, J Thariat, C Cartier, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|October 16, 2020
Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL), part I: Primary treatment of pleomorphic adenomaS Vergez, N Fakhry, C Cartier, et al.
International Journal for Parasitology|April 14, 2016
Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome populationFrédéric D Chevalier, Winka Le Clec'h, Nina Eng, et al.
Pharmaceutics|July 27, 2022
Schistosome Sulfotransferases: Mode of Action, Expression and LocalizationMeghan A Guzman, Anastasia Rugel, Sevan N Alwan, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 22, 2020
Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?Anastasia R Rugel, Meghan A Guzman, Alexander B Taylor, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
ACS Medicinal Chemistry Letters|October 23, 2018
Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal AgentsAnastasia Rugel, Reid S Tarpley, Ambrosio Lopez, et al.
Plos Neglected Tropical Diseases|August 19, 2020
An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humansMeghan A Guzman, Anastasia R Rugel, Reid S Tarpley, et al.
Molecular Biology and Evolution|June 29, 2019
Ancient Hybridization and Adaptive Introgression of an Invadolysin Gene in Schistosome ParasitesRoy N Platt, Marina McDew-White, Winka Le Clec'h, et al.
Pageof 19